Literature DB >> 9283125

Serum and urinary amino acid levels in sickle cell disease.

D J VanderJagt1, G J Kanellis, C Isichei, A Patuszyn, R H Glew.   

Abstract

Neonates with sickle cell disease (SCD) are of normal size at birth in terms of height and weight. However, by the sixth month of life their growth begins to lag significantly behind that of non-sicklers. We hypothesize that such growth retardation could be explained, at least in part, by the increased excretion of free amino acids in the urine of children with SCD. It is well established that in SCD there are abnormalities in the proximal tubules where amino acids are reabsorbed. We collected serum and urine samples from 13 patients with SCD (age range, 10 months to 14 years), and 17 age-and gender-matched controls, and analysed these specimens for free amino acids and creatinine. The SCD population was less well nourished than the controls, as evidenced by the lower serum prealbumin levels in the former group (91.3 v. 127 mg/l, P = 0.01). The serum concentrations of all of the essential amino acids were significantly reduced (21-47 per cent, P < 0.01) in the SCD subjects, as were those of most of the non-essential amino acids (exceptions: alanine, glutamic acid, proline). The urine concentrations of seven of the essential amino acids (indexed to creatinine) were increased in the SCD children. The greatest difference in urinary amino acid excretion was seen with methionine; the SCD subjects excreted 3.6-fold more methionine than the controls. These data indicate that reduced levels of serum amino acids resulting from increased urinary loss of these amino acids in children with SCD could contribute to the decreased growth rates one sees in children with this genetically inherited hematologic disorder.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9283125     DOI: 10.1093/tropej/43.4.220

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  11 in total

1.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

2.  Brain volume in pediatric patients with sickle cell disease: evidence of volumetric growth delay?

Authors:  R Grant Steen; Temitope Emudianughe; Michael Hunte; John Glass; Shengjie Wu; Xiaoping Xiong; Wilburn E Reddick
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

3.  Glutamine supplementation in sick children: is it beneficial?

Authors:  Elise Mok; Régis Hankard
Journal:  J Nutr Metab       Date:  2011-11-14

4.  Ambient air pollution and sickle cell disease-related emergency department visits in Atlanta, GA.

Authors:  Amelia H Blumberg; Stefanie T Ebelt; Donghai Liang; Claudia R Morris; Jeremy A Sarnat
Journal:  Environ Res       Date:  2020-02-27       Impact factor: 6.498

5.  Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.

Authors:  Robert Carter; Joshua Wolf; Tim van Opijnen; Patricia M Flynn; Elaine I Tuomanen; Jason W Rosch; Martha Muller; Caroline Obert; Corinna Burnham; Beth Mann; Yimei Li; Randall T Hayden; Tamara Pestina; Derek Persons; Andrew Camilli
Journal:  Cell Host Microbe       Date:  2014-05-14       Impact factor: 21.023

6.  Reduced cholesterol levels in African-American adults with sickle cell disease.

Authors:  Jaimie Shores; John Peterson; Dorothy VanderJagt; Robert H Glew
Journal:  J Natl Med Assoc       Date:  2003-09       Impact factor: 1.798

7.  Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients.

Authors:  Nadia S Metwally; Sanaa A Ali; Azza M Mohamed; Hussein M Khaled; Samia A Ahmed
Journal:  Cancer Cell Int       Date:  2011-04-07       Impact factor: 5.722

Review 8.  Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.

Authors:  Claudia R Morris; Mark T Gladwin; Gregory J Kato
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

9.  Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial.

Authors:  Sharon E Cox; Elizabeth A Ellins; Alphonce I Marealle; Charles R Newton; Deogratias Soka; Philip Sasi; Gian Luca Di Tanna; William Johnson; Julie Makani; Andrew M Prentice; Julian P Halcox; Fenella J Kirkham
Journal:  Lancet Haematol       Date:  2018-03-13       Impact factor: 30.153

10.  Amino acids and fatty acids in patients with beta thalassemia major.

Authors:  Tugba Koca; Duran Canatan; Ahmet Rifat Örmeci; Yavuz Savas Koca; Handan Duman; Aslı Baykal; Mustafa Akcam
Journal:  Acta Biomed       Date:  2020-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.